| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | 1.11e-04 | 749 | 14 | 5 | GO:0005509 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 4.64e-04 | 46 | 14 | 2 | GO:0030020 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 1.09e-07 | 187 | 14 | 5 | GO:0007156 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 1.39e-06 | 313 | 14 | 5 | GO:0098742 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | 2.58e-06 | 1077 | 14 | 7 | GO:0098609 | |
| GeneOntologyCellularComponent | collagen trimer | 1.54e-03 | 88 | 14 | 2 | GO:0005581 | |
| Domain | Cadherin_CBD | 4.55e-11 | 37 | 14 | 5 | IPR031904 | |
| Domain | Cadherin_tail | 4.55e-11 | 37 | 14 | 5 | PF15974 | |
| Domain | Cadherin_N | 8.53e-10 | 65 | 14 | 5 | IPR013164 | |
| Domain | Cadherin_2 | 8.53e-10 | 65 | 14 | 5 | PF08266 | |
| Domain | Cadherin_CS | 1.18e-08 | 109 | 14 | 5 | IPR020894 | |
| Domain | Cadherin | 1.42e-08 | 113 | 14 | 5 | PF00028 | |
| Domain | CADHERIN_1 | 1.42e-08 | 113 | 14 | 5 | PS00232 | |
| Domain | - | 1.49e-08 | 114 | 14 | 5 | 2.60.40.60 | |
| Domain | CADHERIN_2 | 1.49e-08 | 114 | 14 | 5 | PS50268 | |
| Domain | CA | 1.55e-08 | 115 | 14 | 5 | SM00112 | |
| Domain | Cadherin-like | 1.62e-08 | 116 | 14 | 5 | IPR015919 | |
| Domain | Cadherin | 1.77e-08 | 118 | 14 | 5 | IPR002126 | |
| Domain | Cadherin_C_2 | 4.42e-04 | 42 | 14 | 2 | PF16492 | |
| Domain | Cadherin_C | 4.42e-04 | 42 | 14 | 2 | IPR032455 | |
| Domain | Collagen | 1.80e-03 | 85 | 14 | 2 | IPR008160 | |
| Domain | Collagen | 1.80e-03 | 85 | 14 | 2 | PF01391 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 2.29e-04 | 41 | 8 | 2 | MM15538 | |
| Pathway | PID_ECADHERIN_STABILIZATION_PATHWAY | 2.29e-04 | 41 | 8 | 2 | M232 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 2.63e-04 | 44 | 8 | 2 | M27812 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 2.88e-04 | 46 | 8 | 2 | M198 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 5.07e-04 | 61 | 8 | 2 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 5.58e-04 | 64 | 8 | 2 | M26953 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 6.12e-04 | 67 | 8 | 2 | M26999 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 7.46e-04 | 74 | 8 | 2 | M160 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 7.86e-04 | 76 | 8 | 2 | MM14573 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 7.86e-04 | 76 | 8 | 2 | MM14867 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 9.83e-04 | 85 | 8 | 2 | M16441 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.10e-03 | 90 | 8 | 2 | M631 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.64e-03 | 140 | 8 | 2 | M587 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 8.69e-03 | 258 | 8 | 2 | MM14572 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.16e-02 | 300 | 8 | 2 | M610 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 2.18e-02 | 418 | 8 | 2 | MM15587 | |
| Pubmed | 1.42e-14 | 15 | 14 | 5 | 15640798 | ||
| Pubmed | 2.91e-14 | 17 | 14 | 5 | 29911975 | ||
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | 4.04e-14 | 18 | 14 | 5 | 10662547 | |
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | 4.04e-14 | 18 | 14 | 5 | 15570159 | |
| Pubmed | 2.00e-13 | 24 | 14 | 5 | 24698270 | ||
| Pubmed | Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. | 5.41e-12 | 11 | 14 | 4 | 9655502 | |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | 1.96e-11 | 57 | 14 | 5 | 32633719 | |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | 2.14e-11 | 58 | 14 | 5 | 30377227 | |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 4.86e-11 | 68 | 14 | 5 | 11230163 | |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 6.51e-11 | 72 | 14 | 5 | 10380929 | |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 7.50e-11 | 74 | 14 | 5 | 10817752 | |
| Pubmed | 7.82e-11 | 193 | 14 | 6 | 22589738 | ||
| Pubmed | 9.19e-11 | 77 | 14 | 5 | 10835267 | ||
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 1.12e-10 | 80 | 14 | 5 | 10716726 | |
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | 3.34e-10 | 28 | 14 | 4 | 15347688 | |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | 8.42e-10 | 119 | 14 | 5 | 28625976 | |
| Pubmed | 4.36e-09 | 9 | 14 | 3 | 12154121 | ||
| Pubmed | Proteins of the CNR family are multiple receptors for Reelin. | 1.14e-08 | 12 | 14 | 3 | 10612399 | |
| Pubmed | The DNA sequence and comparative analysis of human chromosome 5. | 1.96e-08 | 75 | 14 | 4 | 15372022 | |
| Pubmed | 1.50e-06 | 5 | 14 | 2 | 34888534 | ||
| Pubmed | 7.42e-05 | 209 | 14 | 3 | 36779422 | ||
| Pubmed | α-catenin interaction with YAP/FoxM1/TEAD-induced CEP55 supports liver cancer cell migration. | 8.89e-05 | 35 | 14 | 2 | 37381005 | |
| Pubmed | Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. | 2.78e-04 | 327 | 14 | 3 | 15592455 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 2.81e-04 | 62 | 14 | 2 | 28344315 | |
| Pubmed | 2.83e-04 | 329 | 14 | 3 | 17474147 | ||
| Interaction | PCDHA10 interactions | 1.06e-09 | 22 | 14 | 4 | int:PCDHA10 | |
| Interaction | PCDHA8 interactions | 4.87e-08 | 55 | 14 | 4 | int:PCDHA8 | |
| Interaction | PCDHA7 interactions | 9.67e-08 | 14 | 14 | 3 | int:PCDHA7 | |
| Interaction | PCDHA11 interactions | 2.57e-07 | 19 | 14 | 3 | int:PCDHA11 | |
| Interaction | PCDHA9 interactions | 1.31e-06 | 32 | 14 | 3 | int:PCDHA9 | |
| Interaction | FLT3 interactions | 1.69e-06 | 318 | 14 | 5 | int:FLT3 | |
| Interaction | PCDHA12 interactions | 3.98e-06 | 46 | 14 | 3 | int:PCDHA12 | |
| Interaction | PCDHA4 interactions | 8.92e-06 | 60 | 14 | 3 | int:PCDHA4 | |
| Interaction | FRMD5 interactions | 1.30e-05 | 68 | 14 | 3 | int:FRMD5 | |
| Interaction | PCDHGA10 interactions | 7.61e-05 | 19 | 14 | 2 | int:PCDHGA10 | |
| Interaction | COL17A1 interactions | 2.48e-04 | 34 | 14 | 2 | int:COL17A1 | |
| Interaction | MAP3K6 interactions | 5.60e-04 | 51 | 14 | 2 | int:MAP3K6 | |
| Interaction | CNNM1 interactions | 6.75e-04 | 56 | 14 | 2 | int:CNNM1 | |
| Interaction | TMEM223 interactions | 7.24e-04 | 58 | 14 | 2 | int:TMEM223 | |
| Interaction | LONP2 interactions | 8.27e-04 | 62 | 14 | 2 | int:LONP2 | |
| Cytoband | 5q31 | 1.78e-10 | 115 | 14 | 5 | 5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 2.13e-08 | 298 | 14 | 5 | chr5q31 | |
| GeneFamily | Clustered protocadherins | 5.97e-10 | 64 | 13 | 5 | 20 | |
| GeneFamily | Collagens | 4.85e-04 | 46 | 13 | 2 | 490 | |
| Coexpression | LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN | 1.70e-06 | 45 | 14 | 3 | M13714 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | 6.18e-06 | 238 | 14 | 4 | M2020 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | 8.89e-06 | 261 | 14 | 4 | MM1277 | |
| Coexpression | NABA_COLLAGENS | 2.36e-04 | 43 | 14 | 2 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 2.47e-04 | 44 | 14 | 2 | M3005 | |
| Drug | Azacitidine | 9.42e-05 | 415 | 14 | 4 | ctd:D001374 | |
| Drug | Zardaverine [101975-10-4]; Up 200; 15uM; HL60; HT_HG-U133A | 1.55e-04 | 176 | 14 | 3 | 2926_UP | |
| Drug | Acetaminophen [103-90-2]; Up 200; 26.4uM; PC3; HT_HG-U133A | 2.16e-04 | 197 | 14 | 3 | 6284_UP | |
| Drug | Gentamicine sulfate [1405-41-0]; Up 200; 2.6uM; PC3; HT_HG-U133A | 2.16e-04 | 197 | 14 | 3 | 5883_UP | |
| Drug | Chlorphensin carbamate [886-74-8]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 2.16e-04 | 197 | 14 | 3 | 2279_UP | |
| Drug | GK-101 | 2.19e-04 | 36 | 14 | 2 | CID000161853 | |
| Drug | Myosmine [532-12-7]; Up 200; 27.4uM; PC3; HT_HG-U133A | 2.20e-04 | 198 | 14 | 3 | 4293_UP | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 2.20e-04 | 198 | 14 | 3 | 2269_UP | |
| Drug | Pinacidil [85371-64-8]; Up 200; 16.4uM; HL60; HT_HG-U133A | 2.23e-04 | 199 | 14 | 3 | 2406_UP | |
| Drug | Cyclacillin [3485-14-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.23e-04 | 199 | 14 | 3 | 3882_UP | |
| Drug | Ritodrine hydrochloride [23239-51-2]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 2.23e-04 | 199 | 14 | 3 | 2635_UP | |
| Drug | Ethynylestradiol 3-methyl ether [72-33-3]; Down 200; 12.8uM; HL60; HT_HG-U133A | 2.26e-04 | 200 | 14 | 3 | 3008_DN | |
| Disease | visceral adipose tissue measurement, body mass index | 3.89e-10 | 87 | 14 | 5 | EFO_0004340, EFO_0004765 | |
| Disease | 1,5 anhydroglucitol measurement | 7.48e-10 | 29 | 14 | 4 | EFO_0008009 | |
| Disease | neutrophil count, basophil count | 3.05e-06 | 224 | 14 | 4 | EFO_0004833, EFO_0005090 | |
| Disease | post-traumatic stress disorder symptom measurement | 7.36e-06 | 82 | 14 | 3 | EFO_0008535 | |
| Disease | Abnormality of refraction | 1.03e-05 | 673 | 14 | 5 | HP_0000539 | |
| Disease | pulse pressure measurement | 2.36e-05 | 1392 | 14 | 6 | EFO_0005763 | |
| Disease | post-traumatic stress disorder | 1.09e-04 | 202 | 14 | 3 | EFO_0001358 | |
| Disease | neuroticism measurement, cognitive function measurement | 1.15e-04 | 566 | 14 | 4 | EFO_0007660, EFO_0008354 | |
| Disease | vital capacity | 1.87e-04 | 1236 | 14 | 5 | EFO_0004312 | |
| Disease | overall survival, pancreatic carcinoma | 2.43e-04 | 49 | 14 | 2 | EFO_0000638, EFO_0002618 | |
| Disease | intraocular pressure measurement | 1.61e-03 | 509 | 14 | 3 | EFO_0004695 | |
| Disease | Hereditary hearing loss and deafness | 2.13e-03 | 146 | 14 | 2 | cv:C0236038 | |
| Disease | Leukemia, Myelocytic, Acute | 2.97e-03 | 173 | 14 | 2 | C0023467 | |
| Disease | neutrophil count | 3.29e-03 | 1382 | 14 | 4 | EFO_0004833 | |
| Disease | Disorder of eye | 4.42e-03 | 212 | 14 | 2 | C0015397 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 5.58e-03 | 239 | 14 | 2 | EFO_0010934 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FQGFPGVKGEKGNPG | 1311 | Q01955 | |
| GFQNFVGLPGKPGPK | 516 | Q07092 | |
| GKYPKAPEGGEGAQP | 391 | Q6W2J9 | |
| FKYGPGNPKQSGPGE | 856 | Q9UN72 | |
| PKPKYNPYKQPGGEG | 51 | Q93052 | |
| KYGPGNPKQSGPGEL | 856 | Q9Y5H7 | |
| FKYGPGNPKQSGPGE | 926 | Q9Y5I4 | |
| FKYGPGNPKQSGPGE | 866 | Q9UN74 | |
| PGKGLAQPPQAYFNG | 396 | Q8IZD4 | |
| DFRKNGNGGPGPYVG | 181 | O60716 | |
| KYGPGNPKQSGPGEL | 861 | Q9UN75 | |
| DFYPNGGNKQPGCPK | 226 | Q6XZB0 | |
| TEGINKPGFYKGPAG | 396 | Q9P202 | |
| PTVYSPGKQGFKPKG | 261 | Q9BYN7 | |
| QPEGKGQETYPGPGK | 96 | Q6F5E7 |